Filter the drugs by their COVID-19 status, phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance
COVID-19 status
Phase of research
How it helps
Latest publication
Supporting references
Contradictory references
Bamlanivimab Potential treatment - clinical evidence Experimental Antiviral Jun/23/2022 11 16
mRNA-1273 Emergency use authorization Experimental Vaccine Jun/22/2022 27 1
ChAdOx1 nCoV-19 Emergency use authorization Experimental Vaccine Jan/04/2022 16 1
Tocilizumab Recommended by China's NHC Guidelines Used to treat other disease Other treatment Oct/29/2021 95 23
Rutin Potential treatment - pre-clinical evidence Natural product Antiviral Apr/02/2021 9 0
Hypericin Potential treatment - theoretical effect Natural product Antiviral Mar/08/2021 8 0
Low Molecular Weight Heparin Potential treatment - clinical evidence Used to treat other disease Other treatment Jan/18/2021 6 1
LV::SFL Potential treatment - pre-clinical evidence Experimental Vaccine Dec/16/2020 1 0
KFVPKQPNMIL Potential treatment - theoretical effect Natural product Antiviral Dec/11/2020 1 0
Cyanidin-3-O-glucoside Potential treatment - pre-clinical evidence Natural product Antiviral Dec/08/2020 2 0
Excel (.xslx) CSV (.csv)